L001-0109 Screening compound: N-(3,5-dimethylphenyl)-4-{3-[(4-methylphenyl)methyl]-2-oxoimidazolidin-1-yl}piperidine-1-carboxamide

L001-0109 Screening compound: N-(3,5-dimethylphenyl)-4-{3-[(4-methylphenyl)methyl]-2-oxoimidazolidin-1-yl}piperidine-1-carboxamide
L001-0109 Screening compound: N-(3,5-dimethylphenyl)-4-{3-[(4-methylphenyl)methyl]-2-oxoimidazolidin-1-yl}piperidine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L001-0109
N-(3,5-dimethylphenyl)-4-{3-[(4-methylphenyl)methyl]-2-oxoimidazolidin-1-yl}piperidine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L001-0109

Molecular Formula

C25H32N4O2 (C25 H32 N4 O2)

Compound Name

N-(3,5-dimethylphenyl)-4-{3-[(4-methylphenyl)methyl]-2-oxoimidazolidin-1-yl}piperidine-1-carboxamide

IUPAC name

N-(35-dimethylphenyl)-4-{3-[(4-methylphenyl)methyl]-2-oxoimidazolidin-1-yl}piperidine-1-carboxamide

SMILES

Cc1ccc(CN(CCN2C(CC3)CCN3C(Nc3cc(C)cc(C)c3)=O)C2=O)cc1

InChI

InChI=1S/C25H32N4O2/c1-18-4-6-21(7-5-18)17-28-12-13-29(25(28)31)23-8-10-27(11-9-23)24(30)26-22-15-19(2)14-20(3)16-22/h4-7,14-16,23H,8-13,17H2,1-3H3,(H,26,30)

InChI Key

AGGNUMLWLBVVHP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27225693

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

420.55

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.451

Distribution Coefficient, logD

4.451

Water Solubility, LogSw

-4.21

Polar Surface Area

45.273

Acid Dissociation Constant (pKa)

14.39

Base Dissociation Constant (pKb)

0.25

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

44.00

L001-0109 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with L001-0109 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L001-0109?
Check Price and Availability of L001-0109, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L001-0109 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L001-0109
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L001-0109
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L001-0109 available by request